Jonathan Pritz
Seminars
Wednesday 18th February 2026
Investor Perspectives Panel Discussion: What Drives Philanthropic & Venture Investment in the Challenging Glioblastoma Landscape?
4:30 pm
- Discussing key milestones, translatable models and biomarkers that are prioritized by investors to mitigate the high-risk nature of GBM drug development
- Exploring how philanthropic funds can de-risk early-stage assets for later VC investment, highlighting overlapping interests and divergencies and how to create a compelling value-proposition for both
- Managing venture philanthropy co-investments, public-private partnerships, and strategic alliances, that are essential for accelerating the development of transformative therapies in this challenging field
